Securities Times e Company News, Peking University Pharmaceuticals (000788) announced on the evening of May 11 that recently, the company received the “Drug Registration Certificate” for Ambroxol Hydrochloride Injection approved and issued by the State Drug Administration. Ambroxol hydrochloride is a phlegm-dissolving expectorant, suitable for acute and chronic lung diseases with abnormal sputum secretion and poor expectoration function.